Discover our latest insights, stories, and perspectives
New 2026 studies reveal that cannabis and tobacco co-use is among the most significant schizophrenia risk factors identified in years
Research shows metformin, GLP-1 drugs, and SGLT2 inhibitors may cut dementia risk by up to 70% in type 2 diabetes patients.
Podiatrists across the U.S. are warning GLP-1 users about "Ozempic feet" — painful foot changes caused by rapid fat pad loss.
New research in JAMA Network Open finds 1 in 3 older men experience no benefit from tamsulosin
The Taco Bell cyclosporiasis outbreak investigation has put over 6,700 US cases under scrutiny.
A cardiovascular surgeon who survived his own heart attack shares 8 warning signs that can precede a cardiac event
A 2026 JAMA study found the Alzheimer's blood test p-tau217 predicts cognitive impairment risk up to a decade early in symptom-free older
A record-breaking cyclosporiasis outbreak has hit 34 states in 2026. Learn the symptoms, why hand sanitizer fails
A 2026 Yale-led study of 31,242 veterans found a surprising link between neighborhoods and pancreatic cancer diagnosis rates
The 2024 Lancet Commission found 14 dementia prevention factors could stop nearly half of all cases.
The WHO's 2026 cancer forecast projects nearly 35 million new cases annually by 2050
Pelvic floor dysfunction and pelvic organ prolapse affect up to 1 in 3 women, yet most go undiagnosed.
